Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants

被引：20

作者：

Almeida, Volia De Carvalho ^{[1
]}

Mussi-Pinhata, Marisa Marcia ^{[2
]}

Sandoval De Souza, Cleonice Barbosa ^{[2
]}

Kubo, Christina Arslanian ^{[3
]}

Martinez, Edson Zangiacomi ^{[4
]}

Carneiro-Sampaio, Magda Maria ^{[5
]}

Duarte, Geraldo ^{[6
]}

机构：

[1] Univ Fed Sao Carlos, Biol & Hlth Sci Ctr, Dept Med, BR-13565905 Sao Carlos, SP, Brazil

[2] Univ Sao Paulo, Dept Pediat, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil

[3] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil

[4] Univ Sao Paulo, Dept Social Med, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil

[5] Univ Sao Paulo, Dept Pediat, Fac Med, BR-05403900 Sao Paulo, Brazil

[6] Univ Sao Paulo, Dept Gynecol & Obstet, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil

来源：

VACCINE | 2009年 / 27卷 / 29期

基金：

巴西圣保罗研究基金会;

关键词：

Pneumococcal polysaccharide vaccine; HIV-infected pregnant woman; Passively acquired pneumococcal antibodies; MATERNAL IMMUNIZATION; STREPTOCOCCUS-PNEUMONIAE; PLACENTAL-TRANSFER; 22F POLYSACCHARIDE; CONJUGATE VACCINE; VIRAL LOAD; SERUM IGG; DISEASE; ADULTS; TRANSMISSION;

D O I：

10.1016/j.vaccine.2009.04.018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Whether gestational immunization of HIV-infected mothers with the 23-valent pneumococcal polysaccharide vaccine (PPV) confers maternal and infant early life, passive protection is not known. We evaluated safety, immunogenicity and placental transfer of antibodies in 44 HIV-infected women. Pneumococcal IgG antibodies against serotypes 1, 3, 5, 613, 9V, and 14 were measured in mothers (pre-vaccination and at delivery), and infants (at birth, 1, 2, 3, and 6 months). PPV was safe and immunogenic in mothers. Newborns received 46-72% of maternal antibody titers. Overall, infants had antibody levels lower than protective by 2 months of age. Alternative pneumococcal vaccination of HIV-infected pregnant women should be explored with the aim of prolonging passive protection in their infants. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：3856 / 3861

页数：6

共 50 条

[31] Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults [J].

Schmoele-Thoma, Beate ;

van Cleeff, Martin ;

Greenberg, Richard N. ;

Gurtman, Alejandra ;

Jones, Thomas R. ;

Sundaraiyer, Vani ;

Gruber, William C. ;

Scott, Daniel A. .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) :575-583

[32] 23-valent pneumococcal polysaccharide vaccine elicits hierarchical antibody and cellular responses in healthy and tuberculosis-cured elderly, and HIV-1-infected subjects [J].

Huang, Huichang ;

Qian, Xiaohua ;

Pan, Rong ;

Shen, Ling ;

Liang, Shanshan ;

Wang, Feifei ;

Zhang, Peng ;

Shen, Hongbo ;

Chen, Zheng W. .

CLINICAL IMMUNOLOGY, 2018, 193 :1-9

[33] Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine [J].

Peterson, James T. ;

Stacey, Helen L. ;

MacNair, John E. ;

Li, Jianing ;

Hartzel, Jonathan S. ;

Sterling, Tina M. ;

Benner, Patrice ;

Tamms, Gretchen M. ;

Musey, Luwy K. .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) :540-548

[34] Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial [J].

Okinaka, Keiji ;

Akeda, Yukihiro ;

Inamoto, Yoshihiro ;

Fuji, Shigeo ;

Ito, Ayumu ;

Tanaka, Takashi ;

Kurosawa, Saiko ;

Kim, Sung-Won ;

Tanosaki, Ryuji ;

Yamashita, Takuya ;

Ohwada, Chikako ;

Kurata, Keiji ;

Mori, Takeshi ;

Onozawa, Masahiro ;

Takano, Kuniko ;

Yokoyama, Hiroki ;

Koh, Katsuyoshi ;

Nagafuji, Koji ;

Nakayama, Kazutaka ;

Sakura, Toru ;

Takahashi, Tsutomu ;

Oishi, Kazunori ;

Fukuda, Takahiro .

CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (04) :482-489

[35] A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly [J].

Huang, Lili ;

Wang, Ling ;

Li, Hong ;

Hu, Yuansheng ;

Ru, Weiping ;

Han, Weixiao ;

Shi, Gang ;

Ye, Qiang ;

Han, Zhen ;

Xia, Jielai ;

Xia, Shengli ;

Xu, Miao ;

Li, Jing .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (01) :249-255

[36] Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature [J].

Cripps, Allan W. ;

Folaranmi, Temitope ;

Johnson, Kelly D. ;

Musey, Luwy ;

Niederman, Michael S. ;

Buchwald, Ulrike K. .

EXPERT REVIEW OF VACCINES, 2021, 20 (03) :257-267

[37] Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12-to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine [J].

Thisyakorn, Usa ;

Chokephaibulkit, Kulkanya ;

Kosalaraksa, Pope ;

Benjaponpitak, Suwat ;

Pancharoen, Chitsanu ;

Chuenkitmongkol, Sunate .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (07) :1859-1865

[38] Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults [J].

Grabenstein, John D. ;

Manoff, Susan B. .

VACCINE, 2012, 30 (30) :4435-4444

[39] 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae [J].

Chandler, Thomas ;

Furmanek, Stephen ;

Carrico, Ruth ;

Balcom, Dawn ;

Arnold, Forest ;

Ramirez, Julio .

MICROORGANISMS, 2022, 10 (03)

[40] Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study [J].

Cordonnier, Catherine ;

Ljungman, Per ;

Juergens, Christine ;

Maertens, Johan ;

Selleslag, Dominik ;

Sundaraiyer, Vani ;

Giardina, Peter C. ;

Clarke, Keri ;

Gruber, William C. ;

Scott, Daniel A. ;

Schmoele-Thoma, Beate .

CLINICAL INFECTIOUS DISEASES, 2015, 61 (03) :313-323

← 1 2 3 4 5 →